SWOG S2210

Primary Category:

Treatment Protocols

Disease Category:

Genitourinary, Prostate

Status:

New, Open

A Phase II Study of Neoadjuvant Carboplatin for Localized, High Risk Prostate Cancer with Germline BRCA1/2 Mutations

NCT#05806515